Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Print
Session IX: Hepatocellular Cancer
SO-14: Atezolizumab Plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: An international study
Thursday, June 30, 2022
15:58 – 16:06
Location: Auditorium A; Level 0
Abstract Presenter(s)
AC
Andrea Casadei-Gardini
